Related Experiment Videos
[Thalassemia major manifested by megaloblastic anemia caused by folate deficiency]
Archives Francaises De Pediatrie
|December 1, 1983
Insights
Thalassemia major in an infant presented with severe anemia and low reticulocyte counts. Folic acid deficiency, due to low intake and high demand, was identified as a key factor requiring daily supplementation.
Area of Science:
- Pediatric Hematology
- Nutritional Deficiencies
- Genetic Blood Disorders
Background:
- Thalassemia major is a severe inherited blood disorder requiring lifelong management.
- Nutritional deficiencies, particularly folate, can complicate the clinical picture in children with chronic hemolytic anemias.
- Early diagnosis and management are crucial for improving outcomes in pediatric hematological conditions.
Observation:
- An 11-month-old infant presented with profound anemia, reticulocytopenia, and megaloblastosis on bone marrow examination.
- These findings, initially suggestive of a primary hematological disorder, were investigated further.
- Bone marrow morphology indicated a complex etiology beyond typical thalassemia presentation.
Findings:
- The patient was diagnosed with thalassemia major.
- Concurrent folic acid deficiency was identified, likely due to inadequate dietary intake and increased physiological demands.
- This deficiency contributed significantly to the observed anemia and megaloblastic changes.
Implications:
- Folic acid supplementation is essential for patients with thalassemia major, especially when co-existing deficiencies are present.
- Recognizing and treating folate deficiency can mitigate severe anemia and improve hematological parameters in these vulnerable patients.
- This case highlights the importance of nutritional assessment in managing complex pediatric anemias.
Abstract:
In a 11 month-old child, a deep anemia with reticulocytopenia and megaloblastosis on bone marrow aspiration revealed a thalassemia major. The low folate intake and the increased needs probably account for initial findings. Folic acid deficiency has already been described in patients with dyserythropoiesis or chronic hemolysis. Daily folic acid treatment is necessary in these patients.